⚠️ This provider averages 1.1K services per working day — physically unusual for an individual practitioner
Based on 2.9M total services over 10 years (250 working days/year). Learn about impossible service volumes →
This provider's $21.7M in total Medicare payments ranks in the 99th percentile of Hematology-Oncology providers nationally.
Averaging 1.1K services per working day raises questions about billing patterns.
Medicare payments to this provider grew 61% from 2014 to 2023.
AI-generated analysis based on Medicare payment data.
Notable: Payments increased 186% in 2023
Year-over-year payment surges can indicate changes in practice volume, new services, or billing pattern shifts.
Average per-service amounts submitted by the provider compared to what Medicare actually paid — the gap represents the markup.
| Year | Avg Submitted | Avg Paid | Markup Ratio | Gap per Service | Total Payments | Services | Beneficiaries |
|---|---|---|---|---|---|---|---|
| 2014 | $25.02 | $6.57 | 3.81x | $18.45 | $1.9M | 288.1K | 38 |
| 2015 | $31.31 | $7.21 | 4.34x | $24.10 | $1.8M | 252.0K | 43 |
| 2016 | $35.42 | $8.02 | 4.42x | $27.40 | $2.2M | 279.7K | 38 |
| 2017 | $32.36 | $8.26 | 3.92x | $24.10 | $2.5M | 301.9K | 43 |
| 2018 | $32.63 | $8.62 | 3.79x | $24.01 | $2.5M | 294.4K | 44 |
| 2019 | $36.46 | $9.05 | 4.03x | $27.41 | $2.7M | 295.4K | 47 |
| 2020 | $25.74 | $6.58 | 3.91x | $19.16 | $1.9M | 285.1K | 49 |
| 2021 | $27.04 | $6.80 | 3.98x | $20.24 | $2.0M | 298.0K | 42 |
| 2022 | $18.68 | $4.08 | 4.58x | $14.60 | $1.1M | 260.7K | 47 |
| 2023 | $39.31 | $10.18 | 3.86x | $29.13 | $3.0M | 299.5K | 51 |
| Code | Description | Services | Payments | Avg/Service | Markup |
|---|---|---|---|---|---|
| J9271 | Injection, pembrolizumab, 1 mg | 115.0K | $4.6M | $40.21 | 3.61x |
| J0897 | Injection, denosumab, 1 mg | 125.8K | $1.8M | $14.46 | 3.47x |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | 14.3K | $1.3M | $90.75 | 3.84x |
| J9310 | Injection, rituximab, 100 mg | 2.0K | $1.2M | $602.15 | 3.59x |
| J0881 | Injection, darbepoetin alfa, 1 microgram (non-esrd use) | 399.1K | $1.2M | $2.90 | 3.95x |
| J9035 | Injection, bevacizumab, 10 mg | 19.2K | $1.1M | $59.05 | 3.39x |
| J2505 | Injection, pegfilgrastim, 6 mg | 358 | $1.1M | $3.0K | 2.84x |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | 8.1K | $961.4K | $118.81 | 3.81x |
| J9299 | Injection, nivolumab, 1 mg | 44.6K | $913.2K | $20.47 | 3.76x |
| J9305 | Injection, pemetrexed, 10 mg | 18.7K | $858.7K | $45.90 | 3.82x |
| Q0138 | Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | 1.1M | $753.7K | $0.70 | 3.89x |
| Q5111 | Injection, pegfilgrastim-cbqv, biosimilar, (udenyca), 0.5 mg | 2.0K | $444.9K | $221.65 | 5.45x |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | 2.9K | $372.4K | $128.96 | 3.57x |
| Q5126 | Injection, bevacizumab-maly, biosimilar, (alymsys), 10 mg | 5.9K | $327.2K | $55.18 | 3.99x |
| J9312 | Injection, rituximab, 10 mg | 4.3K | $318.3K | $73.16 | 3.91x |
| J2469 | Injection, palonosetron hcl, 25 mcg | 30.0K | $315.9K | $10.52 | 4.55x |
| 96367 | Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 10.4K | $271.1K | $25.96 | 4.13x |
| J1627 | Injection, granisetron, extended-release, 0.1 mg | 48.0K | $225.8K | $4.70 | 4.35x |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 3.4K | $200.7K | $58.75 | 3.83x |
| J9041 | Injection, bortezomib, 0.1 mg | 5.2K | $190.8K | $36.59 | 3.83x |
This provider submits charges 4.02 times higher than what Medicare actually pays.
A markup ratio of 4.02x means for every $100 Medicare pays, this provider initially charges $402. This is higher than the national average.
Always verify provider credentials and location before scheduling appointments. This data reflects Medicare payments and may not include all practice locations.
Other Hematology-Oncology providers in MD for peer comparison.
| Provider | Location | Total Payments | Status |
|---|---|---|---|
| David Smith, MD | Easton, MD | $48.3M | ✓ Clear |
| Frederick Smith, M.D. | Chevy Chase, MD | $33.7M | ✓ Clear |
Share this provider's Medicare payment information
Last Updated: February 2026 (data through 2023, the latest CMS release)
Note: All data is from publicly available Medicare records. OpenMedicare is an independent journalism project not affiliated with CMS.
Believe this data is inaccurate? Dispute this data